Anti-HER2 Affibody-Conjugated Photosensitizer for Tumor Targeting Photodynamic Therapy

Volume: 17, Issue: 5, Pages: 1546 - 1557
Published: Apr 8, 2020
Abstract
Antibody-coupled photosensitive molecules can achieve an ideal tumor-specific photodynamic therapy (PDT) and show strong clinical application potential. However, some inherent disadvantages, such as long circulation half-life, poor permeation into solid tumors, and difficulty in obtaining uniform coupling products, present potential problems to clinical applications. In this study, we propose a novel design of targeting photosensitizers, based...
Paper Details
Title
Anti-HER2 Affibody-Conjugated Photosensitizer for Tumor Targeting Photodynamic Therapy
Published Date
Apr 8, 2020
Volume
17
Issue
5
Pages
1546 - 1557
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.